The Eastern Democratic Republic of the Congo is suffering a severe setback in its fight against the Mpox outbreak, six weeks after rebels supported by Rwanda took control of two major cities. The DRC ...

Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a ...

Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and offering ...

The Kenya Union of Clinical Officers, the Ministry of Health and the Council of Governors on Wednesday signed a return-to-work agreement.

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

Africa has seen a sharp rise in public health events, increasing from 152 in 2022 to 213 in 2024, highlighting ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...